Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis

Abstract Objective No efficacious treatments exist to improve or prolong bulbar functions of speech and swallowing in persons with amyotrophic lateral sclerosis (pALS). This study evaluated the short‐term impact of dextromethorphan/quinidine (DMQ) treatment on speech and swallowing function in pALS....

Descrizione completa

Dettagli Bibliografici
Autori principali: Lauren Tabor Gray, Eduardo Locatelli, Terrie Vasilopoulos, James Wymer, Emily K. Plowman
Natura: Articolo
Lingua:English
Pubblicazione: Wiley 2023-08-01
Serie:Annals of Clinical and Translational Neurology
Accesso online:https://doi.org/10.1002/acn3.51821

Documenti analoghi